Longevity science has made significant strides in recent years, as researchers have uncovered new insights into the aging process and developed innovative therapies to extend life and improve health. This article will explore the latest developments in the field of longevity science, with links to government reports and major labs working on curing aging.
National Institute on Aging
The United States’ National Institute on Aging (NIA) is one of the key institutions supporting research into the biology of aging. Their report on the current state of aging research provides a detailed overview of the current understanding of the aging process, as well as the latest scientific approaches being used to develop interventions for age-related diseases.
One of the major focuses of longevity science is the identification of biomarkers of aging, which can be used to predict the likelihood of age-related diseases and evaluate the effectiveness of anti-aging interventions. The NIA has been working on developing the Trans-NIH Geroscience Interest Group, a coordinated effort among various institutes to study aging and its related diseases.
SENS Research Foundation
Several labs have emerged in recent years with the goal of curing aging. The SENS Research Foundation is one such lab, with a focus on developing therapies that can repair damage caused by aging. Their research has identified seven types of damage that contribute to aging, and they are working on developing interventions to address each type of damage.
Buck Institute
Another lab working on curing aging is the Buck Institute for Research on Aging. Their research focuses on identifying the cellular and molecular mechanisms underlying aging, as well as developing interventions to extend lifespan and improve health. One of their major projects is the Interventions Testing Program, which evaluates the effectiveness of potential anti-aging interventions in mice.
BioAge
Kristen Fortney’s BioAge lab is a research group based in California that focuses on developing technologies and therapies to promote healthy aging.
One of the main projects of the BioAge lab is the development of biomarkers of aging. They are working to identify molecular signatures in the blood that can be used to determine a person’s biological age. This could be a more accurate predictor of health outcomes than chronological age alone, and could be used to develop personalized interventions to improve healthspan.
Another project of the BioAge lab is the development of senolytic therapies. Senescent cells are cells that have stopped dividing and are no longer functional, but they continue to accumulate in the body as we age. These cells contribute to inflammation and tissue damage, and are thought to be a major driver of aging. Senolytic therapies target these senescent cells, causing them to undergo cell death, and have shown promise in animal studies as a way to improve health and extend lifespan.
The BioAge lab is also working on developing small molecules that can mimic the effects of calorie restriction, a well-established method of extending lifespan in animals. By identifying these molecules and understanding how they work, the BioAge lab hopes to develop interventions that can improve healthspan in humans.
Overall, the BioAge lab’s research is focused on understanding the molecular mechanisms of aging and developing interventions that can slow or reverse the aging process. Their work has the potential to improve health and quality of life for millions of people as they age.
Calico Labs
Calico Labs is a biotech company that was founded in 2013 with the goal of understanding the biology of aging and developing interventions that can extend healthy lifespan. The company is based in South San Francisco, California, and is a subsidiary of Alphabet Inc., the parent company of Google.
Calico Labs’ research focuses on several key areas, including genetics, genomics, and epigenetics, with the aim of identifying molecular pathways that are involved in aging and age-related diseases such as cancer, Alzheimer’s, and Parkinson’s. The company also conducts research into stem cells, tissue engineering, and regenerative medicine, with the goal of developing therapies that can promote tissue repair and regeneration.
Calico Labs has also partnered with pharmaceutical companies such as AbbVie and C4 Therapeutics to develop therapies for cancer and other age-related diseases.
Overall, Calico Labs is focused on leveraging the latest advances in technology and scientific understanding to tackle some of the biggest challenges facing society today, including aging and disease.
The Paul F. Glenn Center for Biology of Aging Research
The Paul F. Glenn Center for Biology of Aging Research is a research institution that was founded in 2005 with the aim of advancing the understanding of the biology of aging and developing interventions that can extend healthy lifespan. The center is located at Harvard Medical School in Boston, Massachusetts, and is supported by the Glenn Foundation for Medical Research.
The Glenn Center conducts interdisciplinary research that spans a range of fields, including genetics, epigenetics, metabolism, neuroscience, and immunology, among others. Its research is focused on identifying the molecular and cellular mechanisms that underlie the aging process and age-related diseases, such as cancer, Alzheimer’s disease, and cardiovascular disease.
One of the center’s key research initiatives is the study of the biology of longevity in model organisms such as yeast, worms, and mice. By studying the genetic and molecular mechanisms that allow these organisms to live longer and healthier lives, researchers at the Glenn Center hope to identify potential targets for interventions that can extend human lifespan.
The Glenn Center also provides support for early-stage research projects through its Glenn Foundation Awards Program, which funds promising research proposals in the field of aging biology.
Overall, the Paul F. Glenn Center for Biology of Aging Research is dedicated to advancing the field of aging biology and developing interventions that can promote healthy aging and improve quality of life in later years.
More
Other major labs working on longevity research include the Longevity Vision Fund, the Mayo Clinic Center for Regenerative Medicine, and the University of Michigan’s Center on the Demography of Aging.
Longevity science is a rapidly growing field with the potential to revolutionize our understanding of aging and improve health in later life. With the support of government agencies, private organizations, and leading researchers, we can expect to see continued progress in developing interventions to extend lifespan and improve health as we age.